At the time of writing, Sana Biotechnology Inc [SANA] stock is trading at $3.37, down -0.30%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SANA shares have gain 6.65% over the last week, with a monthly amount glided 106.75%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sana Biotechnology Inc [NASDAQ: SANA] stock has seen the most recent analyst activity on January 08, 2025, when TD Cowen upgraded its rating to a Buy. Previously, JMP Securities downgraded its rating to Mkt Perform on November 05, 2024. On June 26, 2024, Rodman & Renshaw initiated with a Buy rating and assigned a price target of $16 on the stock. H.C. Wainwright upgraded its rating to a Buy but stick to its price target of $12 on January 16, 2024. JMP Securities initiated its recommendation with a Mkt Outperform and recommended $9 as its price target on September 25, 2023. Citigroup started tracking with a Buy rating for this stock on September 05, 2023, and assigned it a price target of $8. In a note dated August 14, 2023, TD Cowen initiated an Market Perform rating.
For the past year, the stock price of Sana Biotechnology Inc fluctuated between $1.52 and $12.00. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $3.37 at the most recent close of the market. An investor can expect a potential return of 137.39% based on the average SANA price forecast.
Analyzing the SANA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.94 and Total Capital is -0.58. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.15 points at the first support level, and at 2.94 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.59, and for the 2nd resistance point, it is at 3.81.
Ratios To Look Out For
It is important to note that Sana Biotechnology Inc [NASDAQ:SANA] has a current ratio of 4.47. Further, the Quick Ratio stands at 4.47, while the Cash Ratio is 2.7.
Transactions by insiders
Recent insider trading involved CHRISTIAN HORDO & KATHARINE HO, Officer, that happened on Jan 16 ’25 when 75000.0 shares were purchased. See Remark 1, FMR LLC completed a deal on Jan 08 ’25 to sell 0.29 million shares. Meanwhile, Officer CHRISTIAN HORDO & KATHARINE HO bought 75000.0 shares on Dec 16 ’24.
